一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Accounts of Chemical Research >>article
Accounts of Chemical Research

Accounts of Chemical Research

IF: 16.4
Download PDF

Intravitreal fluocinolone acetonide implant for chronic postoperative cystoid macular edema - two years results.

Published:4 September 2022 DOI: 10.1177/11206721221124688 PMID: 36062617
Argyrios Chronopoulos,?Panagiotis Chronopoulos,?L O Hattenbach,?Agharza Ashurov,?James S Schutz,?Norbert Pfeiffer,?Christina Korb

Abstract

Purpose: We report visual and anatomical outcomes of chronic postoperative macular edema treated with a fluocinolone acetonide intravitreal implant.

Method: Retrospective study of chronic, post-surgical CME treated with a fluocinolone acetonide intravitreal implant. Best registered visual acuity (BRVA), central retinal thickness (CRT), and Goldmann tonometry intraocular pressure (IOP) were assessed over 24 months. The need for IOP lowering treatment, top-up therapy during follow-up, and complications were also assessed.

Results: We analyzed 16 consecutive eyes of 16 patients with chronic, post-surgical CME treated with fluocinolone acetonide intravitreal implant. Surgical indications included cataract surgery, vitrectomy plus membrane peeling and combined phaco-vitrectomy. Baseline mean BRVA of 0.8?±?0.65 logMAR improved to 0.60?±?0.4 logMAR (p?=?0.02) at 12 months and to 0.7?±?0.5 logMAR (p?=?0.32) at 24 months. At month 12, BRVA improved in 11 eyes, stabilized in 4 eyes, and decreased in 1 eye. At month 24, VA remained improved in 5 eyes, remained stabilized in 5 eyes, and decreased in 1 eye. Mean CRT decreased from 524?±?132?μm at baseline to 389?μm at month 3, 347?μm at month 6, 355?±?106?μm (p?=?0.0003) at month 12, and 313?±?83?μm (p?=?0.0001) at month 24. At 12 months, CRT improved in 13 eyes and remained unchanged in 2 eyes. At 24 months, CRT improved further in 8 eyes, and stabilized in 3 eyes. Increased IOP (≥21?mmHg) was observed only in 4 eyes, all successfully managed with topical medication. No further side effects were observed in any patient.

Conclusion: Visual and anatomic improvements were achieved by a single fluocinolone acetonide implant with few side effects up to 24 months in CME eyes with a long and heavy prior treatment history.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Fluocinolone Acetonide 67-73-2 C24H30F2O6 507 suppliers $28.00-$1674.75

Similar articles

IF:4.3

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

ACS Applied Electronic Materials Noemi Lois, Evie Gardner,etc Published: 14 July 2020
图木舒克市| 大关县| 柘城县| 双辽市| 平阳县| 来凤县| 崇仁县| 柳江县| 苗栗县| 大兴区| 崇礼县| 新民市| 寻乌县| 遵义县| 绿春县| 道孚县| 苍山县| 江源县| 高雄市| 东乡族自治县| 泗水县| 惠安县| 富阳市| 海兴县| 丹凤县| 十堰市| 江源县| 沅陵县| 沁源县| 永兴县| 甘谷县| 望城县| 陵水| 安徽省| 玛沁县| 资溪县| 大厂| 青河县| 乡宁县| 慈利县| 富顺县|